SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > Stock Clubs > Technical Analysis >

TRADING SA, MNKD,VRX,SRPT

RSS Feed
      Hide Sticky   Hide Intro
Moderator: TREND1 Assistants:
Search This Board: 
Last Post: 5/23/2017 4:56:47 PM - Followers: 2 - Board type: Premium - Posts Today: 0

TRADING SA
PostSubject
#108   5/23 MannKind Contract With Amphastar TREND1 05/23/17 04:56:47 PM
#107   5/21 MannKind - Afrezza Adverse Events Since Launch TREND1 05/21/17 08:23:13 PM
#106   5/19 Afrezza: What Is Possible Vs. What Is Probable TREND1 05/19/17 03:01:39 PM
#105   5/18 Reading MannKind's SEC Documents Would Help Investors TREND1 05/18/17 02:13:29 PM
#103   5/12 MannKind - Afrezza Script Sales Stable But Low TREND1 05/12/17 04:47:14 PM
#101   5/12 Mannkind Q1: Nothing But Losses TREND1 05/12/17 11:44:45 AM
#100   5/11 MannKind Reports Q1 Loss - What Investors TREND1 05/11/17 12:30:24 PM
#99   5/11 MannKind Q1 revenue disappoints, shares down 15% TREND1 05/11/17 12:09:47 PM
#98   5/10 MannKind's (MNKD) CEO Matthew Pfeffer on Q1 TREND1 05/10/17 11:40:17 PM
#96   5/8 MannKind Making Moves, Could Gain Nasdaq Compliance TREND1 05/08/17 05:00:12 PM
#95   5/5 MannKind: Afrezza Sales Still Low As Company TREND1 05/05/17 02:37:16 PM
#94   5/2 MannKind Hopes To Reverse Fortunes With Television Show TREND1 05/02/17 04:27:46 PM
#93   5/1 MannKind: Mann Trust Executors Are Selling Massive TREND1 05/01/17 02:57:13 PM
#92   4/28 MannKind - Afrezza Scripts Dip Again TREND1 04/28/17 01:42:24 PM
#91   4/25 MannKind May Not Go Bankrupt, But... TREND1 04/25/17 07:01:32 PM
#90   4/25 MannKind Corporation Needs A Merger TREND1 04/25/17 09:54:49 AM
#89   4/21 MannKind Under A Buck - New Script TREND1 04/21/17 01:37:44 PM
#87   4/20 MannKind Renegotiates Debt With Dilution - What TREND1 04/20/17 11:50:39 AM
#86   4/17 MannKind - Stagnant Sales Demand That Investors TREND1 04/17/17 12:57:38 PM
#85   4/13 First patient in Asia implanted with Second TREND1 04/13/17 11:06:23 AM
#84   4/10 MannKind Closes Out Worst Full Quarter Of TREND1 04/10/17 10:52:17 AM
#83   4/4 Flexion Therapeutics issues two new patents to TREND1 04/04/17 11:06:55 AM
#82   4/3 MannKind: Afrezza Scripts Remain Underwhelming TREND1 04/03/17 03:36:12 PM
#81   MannKind Corp.: Bleeding Out And On Its Deathbed TREND1 03/30/17 01:31:43 PM
#80   MannKind: Afrezza Sales Remain Low As Q1 Comes TREND1 03/27/17 11:15:58 AM
#79   Bank Of America: Buy The Dip TREND1 03/21/17 04:02:47 PM
#78   What MannKind's Cash Situation Truly Looks Like TREND1 03/20/17 02:52:50 PM
#77   3/20 MannKind Beats Street With Settlement Revenue; Script TREND1 03/20/17 11:27:41 AM
#76   3/16 MannKind's (MNKD) CEO Matthew Pfeffer on Q4 TREND1 03/16/17 11:46:29 PM
#75   3/14 TREND1 03/14/17 12:27:32 PM
#74   Bank Of America: Historical Indicators Of A Correction TREND1 03/11/17 12:23:13 PM
#73   MannKind Needs To Boost Script Sales - Will TREND1 03/10/17 06:21:44 PM
#72   http://seekingalpha.com/news/3248945-vermillions-aspira-labs-secures-state-provi TREND1 03/07/17 06:24:20 PM
#71   MannKind - Afrezza Sales Struggle As February Comes TREND1 03/06/17 10:14:22 AM
#70   MannKind Enacts Reverse Split At 1-For-5 Ratio: What TREND1 03/03/17 12:42:44 PM
#69   MannKind: Years Before Achieving Break-Even Point TREND1 02/27/17 01:54:42 PM
#68   SCRIPT DATA TREND1 02/27/17 12:20:51 PM
#67   https://en.wikipedia.org/wiki/Artificial_pancreas TREND1 02/19/17 12:45:43 PM
#66   MannKind - Afrezza Sales Slip As New Sales TREND1 02/17/17 04:02:13 PM
#65   MannKind, Afrezza Sales, And 'Free Beer Tomorrow' TREND1 02/10/17 06:30:03 PM
#63   MannKind - Afrezza Sales Improve Slightly, But Not TREND1 02/03/17 07:40:01 PM
#62   MannKind: The Saga Of Smoking Guns TREND1 02/03/17 01:04:43 PM
#61   MannKind Announces Plans For Reverse Split TREND1 02/02/17 11:14:27 AM
#60   Afrezza Sales Still Low As MannKind Prepares For TREND1 01/27/17 07:22:37 PM
#59   MannKind: Afrezza Sales Start Off 2017 Modestly. Will TREND1 01/18/17 10:57:51 AM
#58   MannKind Sells Building, Extends Cash Runway: The Good TREND1 01/12/17 08:30:19 PM
#57   MannKind's (MNKD) CEO Matt Pfeffer Presents at JPMorgan TREND1 01/12/17 05:08:17 PM
#56   MannKind Afrezza Sales - Closing Out The Year TREND1 01/09/17 10:04:29 AM
#55   1/3 MannKind's $1M Milestone: Good News, But Barely TREND1 01/03/17 04:34:37 PM
#54   1/3 Does A Possible Label Change On Afrezza TREND1 01/03/17 01:32:31 PM
PostSubject